NIVF NewGenIvf Group Ltd Insider Trading

HRT Financial LP (10% owner) buys 34,756 shares at blended $0.92 average; stock down 64.9% in 90 days despite 2 recent prior buys at NIVF.

HRT Financial LP, a 10% owner, purchased 34,756 shares across 2 separate transactions (23,018 shares at $0.94 on 2026-06-02 and 11,738 shares at $0.88 on 2026-06-03) for a total of $31,999.74, expanding holdings from 48,323 to 83,079 shares. The transaction occurs at a blended average price of $0.92, while the current price is $0.68 and the stock is -64.9% over 90 days, near its 52-week low relative to a high of $1839.00. The insider's prior 2 trades at NIVF have shown mixed results: the most recent buy on 2026-05-26 returned +0.7% at 90 days, while a buy on 2026-05-22 returned -6.4% at 90 days, with 1 of 2 prior buys well-timed at the 90-day mark. The company has a market cap of $163,622.96.

HRT Financial LP bought 165,534 shares in 2 transactions for $161,919.15 at $0.98 avg; stock now down -100.0% from 52-week high at $0.81.

HRT Financial LP, a 10% owner of NewGenIvf Group Ltd, made 2 separate purchases totaling 165,534 shares for $161,919.15, with a blended average price of $0.98. The current share price of $0.81 is -100.0% from the 52-week high and has declined -58.7% over the last 30 days and -74.5% over the last 90 days. The company's market cap stands at $194,903.82. HRT's historical cross-ticker track record shows 13 prior open-market buys with an average 90-day return of +649.2%, yet this transaction sits in a severe price collapse environment where the stock has cratered near its 52-week low, raising questions about signal quality in distressed conditions. The combination of substantial insider accumulation amid extreme negative price momentum and a micro-cap valuation warrants examination of whether this trade reflects conviction or is disconnected from fundamental deterioration.